Datamonitor, June 2010, Pages: 116
Bayer Schering Pharma AG: PharmaVitae Profile Introduction
This analysis examines the historical and forecast performance for Bayer Schering in the prescription pharma sector. The profile
Datamonitor, Oct 2010, Pages: 95
Astellas Pharma Inc.: PharmaVitae Profile Introduction
This analysis examines the historical and forecast performance for Astellas in the prescription pharmaceutical sector. The profile encompasses
NeuroInsights, May 2011, Pages: 500+
The Neurotechnology Industry 2011 Report Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysisand Strategic Investment Guide of the Global
NeuroInsights, May 2010
The Central Nervous Systems Market 2010 Report Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysisand Strategic Investment Guide of the Global
Global Markets Direct, Feb 2012, Pages: 163
from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third
Global Markets Direct, Feb 2011, Pages: 100
from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third
Global Markets Direct, Sep 2011, Pages: 87
. Hoffmann-La Roche Ltd.
Abbott Laboratories
Amgen Inc.
Eli Lilly and Company
Quark Pharmaceuticals, Inc.
Merck & Co., Inc.
MD Scientific, LLC
Astellas Pharma Inc.
Mitsubishi Tanabe
Global Markets Direct, Dec 2010, Pages: 98
Regeneration At American Society For Transplantation Annual Conference
Oct 18, 2010: Amgen To Review TREAT Results And Propose Updates To ESA Labeling For Chronic Renal Failure Patients At FDA Advisory
Espicom Business Intelligence Ltd, Sep 2009, Pages: 120
), meanwhile BI’s Ben Venue, Bedford and Roxane Laboratories (which operate as consolidated subsidiaries) compete in the global generics market. Consequently, BI has a strong foothold in each of the major types
Global Markets Direct, May 2012, Pages: 285
latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Boehringer Ingelheim GmbH’s
Global Markets Direct, Nov 2011, Pages: 274
with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Boehringer Ingelheim
